TY - JOUR
T1 - Neobladder and ablative pelvic radiotherapy
T2 - still a taboo?
AU - Bergamaschi, Luca
AU - Gerardi, Marianna Alessandra
AU - Zaffaroni, Mattia
AU - Augugliaro, Matteo
AU - Vigorito, Sabrina
AU - Rondi, Elena
AU - Della Vigna, Paolo
AU - Varano, Gianluca
AU - Fumagalli Romario, Uberto
AU - Biffi, Roberto
AU - Picardi, Edgardo Enrico Edoardo
AU - Ferrari, Annamaria
AU - Jereczek-Fossa, Barbara Alicja
N1 - Funding Information:
The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The European Institute of Oncology IRCCS, Milan, Italy, receives research support from the Italian Ministry of Health (Ricerca Corrente and 5x1000 funds). M.Z. received a research grant from Accuray Inc. (data collection and analysis of Tomotherapy® and CyberKnife® breast clinical studies, breast physics studies, and prostate study) outside the current study. The sponsors did not play any role in study design, execution, or data analysis.
Publisher Copyright:
© Fondazione IRCCS Istituto Nazionale dei Tumori 2021.
PY - 2021
Y1 - 2021
N2 - The presence of a neobladder constitutes a limitation for the radiation oncologist, as there is no clear evidence about its tolerance to radiotherapy (RT). The limited literature only concerns the conventional postoperative treatment in patients with bladder cancer after cystectomy. Here we report a case of a patient with neobladder who underwent a stereotactic RT for a pelvic recurrence of disease, with response to treatment and no toxicity to the neobladder. This case represents a promising example of the chance to perform RT with ablative intent, using advanced techniques, even on lesions close to the neobladder.
AB - The presence of a neobladder constitutes a limitation for the radiation oncologist, as there is no clear evidence about its tolerance to radiotherapy (RT). The limited literature only concerns the conventional postoperative treatment in patients with bladder cancer after cystectomy. Here we report a case of a patient with neobladder who underwent a stereotactic RT for a pelvic recurrence of disease, with response to treatment and no toxicity to the neobladder. This case represents a promising example of the chance to perform RT with ablative intent, using advanced techniques, even on lesions close to the neobladder.
KW - ablative radiotherapy
KW - Neobladder
KW - pelvic adenocarcinoma
UR - http://www.scopus.com/inward/record.url?scp=85109421621&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85109421621&partnerID=8YFLogxK
U2 - 10.1177/03008916211031295
DO - 10.1177/03008916211031295
M3 - Article
AN - SCOPUS:85109421621
JO - Tumori
JF - Tumori
SN - 0300-8916
ER -